Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial
Author:
Funder
American Heart Association
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology and Child Health
Link
https://link.springer.com/content/pdf/10.1007/s00246-021-02565-6.pdf
Reference19 articles.
1. Khairy P et al (2010) Changing mortality in congenital heart disease. J Am Coll Cardiol 56(14):1149–1157
2. Butts RJ et al (2015) Estimating equations for cardiopulmonary exercise testing variables in Fontan patients: derivation and validation using a multicenter cross-sectional database. Pediatr Cardiol 36(2):393–401
3. Ovroutski S et al (2010) Long-term cardiopulmonary exercise capacity after modified Fontan operation. Eur J Cardiothorac Surg 37(1):204–209
4. Goldstein BH et al (2010) Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation. Am J Cardiol 105(8):1169–1175
5. Packer M et al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334(21):1349–1355
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiac Drugs in ACHD Cardiovascular Medicine;Journal of Cardiovascular Development and Disease;2023-04-24
2. Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?;International Journal of Molecular Sciences;2022-08-03
3. Effects of Carvedilol on Blood Pressure, Blood Sugar, and Blood Lipids in Elderly Patients with Refractory Hypertension;Computational and Mathematical Methods in Medicine;2022-07-27
4. The Fontan Circulation: From Ideal to Failing Hemodynamics and Drug Therapies for Optimization;Canadian Journal of Cardiology;2022-07
5. Side effects of beta adrenergic antagonists and antianginal drugs;Side Effects of Drugs Annual;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3